Blue Trust Inc’s Medifast MED Stock Holding History

Blue Trust Inc’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-702	Closed	-$15.3K	–	2760
2024 Q3	$15.3K	Buy	702 +686	+4,288%	+$13.2K	﹤0.01%	2049
2024 Q2	$613	Buy	+16	New	+$426	﹤0.01%	2597
2024 Q1	–	Sell	-236	Closed	-$18K	–	2512
2023 Q4	$18K	Buy	236 +159	+206%	+$11.1K	﹤0.01%	1335
2023 Q3	$7K	Sell	77 -15	-16%	-$1.33K	﹤0.01%	1536
2023 Q2	$10K	Buy	92 +88	+2,200%	+$7.83K	﹤0.01%	1308
2023 Q1	$0	Sell	4 -1	-20%	-$111	﹤0.01%	2502
2022 Q4	$1K	Sell	5 -1	-17%	-$116	﹤0.01%	2085
2022 Q3	$1K	Buy	6 +5	+500%	+$716	﹤0.01%	1956
2022 Q2	$0	Buy	+1	New	+$179	﹤0.01%	1957

Other funds holding MED

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return